Drugmakers hiking prices for more than 700 medications, including Ozempic and Mounjaro
CBSN
Pharmaceutical companies are hiking prices for more than 700 medications, including popular weight-loss drugs Ozempic and Mounjara, industry research shows.
The average price increase at year start was about about 4.5%, the analysis from 46 Brooklyn found. That represents a slightly slower pace compared with the five prior years, when drug prices rose about 5% each year on average, the data shows.
Among the noteworthy increases are Ozempic and Mounjara, two drugs that belong to a class of medications called GLP-1 agonists. While these drugs are designed to help diabetics regulate their blood sugar, they've also been found to be effective weight-loss drugs, prompting non-diabetics to seek out the drugs in order to slim down. As a result, these drugs have been in greater demand, leading to shortages.
